SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Avalon GloboCare Corp. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Monday, 4/15/24, at 5:08pm ET   ·   For:  12/31/23   ·   Accession #:  1213900-24-33023   ·   File #:  1-38728

Previous ‘10-K’:  ‘10-K’ on 3/30/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   51 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Avalon GloboCare Corp.            10-K       12/31/23  113:10M                                    EdgarAgents LLC/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.09M 
 2: EX-4.9      Description of Securities Registered Under Section  HTML     55K 
                12 of the Securities Exchange Act of 1934                        
 3: EX-10.50    Consulting Agreement, Dated February 9, 2023, by    HTML     58K 
                and Between Laboratory Services Mso, LLC and Sarah               
                Cox                                                              
 4: EX-23.1     Consent of Independent Registered Accounting Firm   HTML     30K 
 8: EX-97.1     Avalon Globocare Corp. Compensation Recovery        HTML     45K 
                Policy                                                           
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
14: R1          Cover                                               HTML    106K 
15: R2          Audit Information                                   HTML     36K 
16: R3          Consolidated Balance Sheets                         HTML    194K 
17: R4          Consolidated Balance Sheets (Parentheticals)        HTML     58K 
18: R5          Consolidated Statements of Operations and           HTML    153K 
                Comprehensive Loss                                               
19: R6          Consolidated Statements of Operations and           HTML     39K 
                Comprehensive Loss (Parentheticals)                              
20: R7          Consolidated Statements of Changes in Equity        HTML    126K 
21: R8          Consolidated Statements of Cash Flows               HTML    170K 
22: R9          Organization and Nature of Operations               HTML     45K 
23: R10         Basis of Presentation and Going Concern Condition   HTML     38K 
24: R11         Summary of Significant Accounting Policies          HTML     89K 
25: R12         Prepaid Expense and Other Current Assets            HTML     36K 
26: R13         Property and Equipment                              HTML     37K 
27: R14         Investment in Real Estate                           HTML     37K 
28: R15         Equity Method Investments                           HTML     51K 
29: R16         Accrued Liabilities and Other Payables              HTML     37K 
30: R17         Convertible Note Payable                            HTML     73K 
31: R18         Derivative Liability                                HTML     44K 
32: R19         Note Payable, Net                                   HTML     41K 
33: R20         Related Party Transactions                          HTML     49K 
34: R21         Income Taxes                                        HTML     62K 
35: R22         Equity                                              HTML     92K 
36: R23         Statutory Reserve and Restricted Net Assets         HTML     35K 
37: R24         Noncontrolling Interest                             HTML     34K 
38: R25         Condensed Financial Information of the Parent       HTML     35K 
                Company                                                          
39: R26         Concentrations                                      HTML     36K 
40: R27         Segment Information                                 HTML     57K 
41: R28         Commitments and Contincengies                       HTML     44K 
42: R29         Subsequent Events                                   HTML     34K 
43: R30         Pay vs Performance Disclosure                       HTML     43K 
44: R31         Insider Trading Arrangements                        HTML     37K 
45: R32         Accounting Policies, by Policy (Policies)           HTML    150K 
46: R33         Organization and Nature of Operations (Tables)      HTML     39K 
47: R34         Summary of Significant Accounting Policies          HTML     50K 
                (Tables)                                                         
48: R35         Prepaid Expense and Other Current Assets (Tables)   HTML     36K 
49: R36         Property and Equipment (Tables)                     HTML     36K 
50: R37         Investment in Real Estate (Tables)                  HTML     36K 
51: R38         Equity Method Investments (Tables)                  HTML     45K 
52: R39         Accrued Liabilities and Other Payables (Tables)     HTML     37K 
53: R40         Convertible Note Payable (Tables)                   HTML     40K 
54: R41         Note Payable, Net (Tables)                          HTML     37K 
55: R42         Related Party Transactions (Tables)                 HTML     35K 
56: R43         Income Taxes (Tables)                               HTML     62K 
57: R44         Equity (Tables)                                     HTML     68K 
58: R45         Concentrations (Tables)                             HTML     35K 
59: R46         Segment Information (Tables)                        HTML     59K 
60: R47         Commitments and Contincengies (Tables)              HTML     43K 
61: R48         Organization and Nature of Operations (Details)     HTML     57K 
62: R49         Organization and Nature of Operations (Details) -   HTML     57K 
                Schedule of Condensed Consolidated Financial                     
                Statements Reflect the Activities                                
63: R50         Basis of Presentation and Going Concern Condition   HTML     41K 
                (Details)                                                        
64: R51         Summary of Significant Accounting Policies          HTML    111K 
                (Details)                                                        
65: R52         Summary of Significant Accounting Policies          HTML     45K 
                (Details) - Schedule of Derivative Liability                     
                Measured at Fair Value                                           
66: R53         Summary of Significant Accounting Policies          HTML     40K 
                (Details) - Schedule of Cash Balances by                         
                Geographic Area                                                  
67: R54         Summary of Significant Accounting Policies          HTML     49K 
                (Details) - Schedule of Summarizes the Securities                
                that were Excluded from the Diluted Per Share                    
68: R55         Prepaid Expense and Other Current Assets (Details)  HTML     49K 
                - Schedule of Prepaid Expense and Other Current                  
                Assets                                                           
69: R56         Property and Equipment (Details)                    HTML     39K 
70: R57         Property and Equipment (Details) - Schedule of      HTML     49K 
                Property and Equipment                                           
71: R58         Investment in Real Estate (Details)                 HTML     33K 
72: R59         Investment in Real Estate (Details) - Schedule of   HTML     44K 
                Investment in Real Estate                                        
73: R60         Equity Method Investments (Details)                 HTML     71K 
74: R61         Equity Method Investments (Details) - Schedule of   HTML     59K 
                Equity Method Investment                                         
75: R62         Equity Method Investments (Details) - Schedule of   HTML     43K 
                Summarized Financial Information, as Provided to                 
                the Company by the Investee                                      
76: R63         Equity Method Investments (Details) - Schedule of   HTML     63K 
                Financial Information                                            
77: R64         Accrued Liabilities and Other Payables (Details) -  HTML     51K 
                Schedule of Accrued Liabilities and Other Payables               
78: R65         Convertible Note Payable (Details)                  HTML    271K 
79: R66         Convertible Note Payable (Details) - Schedule of    HTML     93K 
                Amortization Payments in Cash                                    
80: R67         Derivative Liability (Details)                      HTML    128K 
81: R68         Note Payable, Net (Details)                         HTML     58K 
82: R69         Note Payable, Net (Details) - Schedule of Note      HTML     38K 
                Payable                                                          
83: R70         Related Party Transactions (Details)                HTML    112K 
84: R71         Related Party Transactions (Details) - Schedule of  HTML     43K 
                Line of Credit                                                   
85: R72         Income Taxes (Details)                              HTML     48K 
86: R73         Income Taxes (Details) - Schedule of Company?s      HTML     39K 
                Loss Before Income Taxes                                         
87: R74         Income Taxes (Details) - Schedule of Components of  HTML     60K 
                Income Taxes Expense (Benefit)                                   
88: R75         Income Taxes (Details) - Schedule of U.S.           HTML     49K 
                Statutory Rate and the Company?s Effective Tax                   
                Rate                                                             
89: R76         Income Taxes (Details) - Schedule of Deferred       HTML     68K 
                Taxes                                                            
90: R77         Equity (Details)                                    HTML    370K 
91: R78         Equity (Details) - Schedule of Common Stock         HTML     64K 
                Issuable Upon Exercise of Options Outstanding                    
92: R79         Equity (Details) - Schedule of Stock Option         HTML     63K 
                Activity                                                         
93: R80         Equity (Details) - Schedule of Nonvested Stock      HTML     55K 
                Options Granted                                                  
94: R81         Equity (Details) - Schedule of Common Stock         HTML     70K 
                Issuable Upon Exercise of Warrants Outstanding                   
95: R82         Statutory Reserve and Restricted Net Assets         HTML     38K 
                (Details)                                                        
96: R83         Noncontrolling Interest (Details)                   HTML     34K 
97: R84         Condensed Financial Information of the Parent       HTML     34K 
                Company (Details)                                                
98: R85         Concentrations (Details)                            HTML     32K 
99: R86         Concentrations (Details) - Schedule of Customer     HTML     41K 
100: R87         Segment Information (Details)                       HTML     32K  
101: R88         Segment Information (Details) - Schedule of         HTML     89K  
                Reportable Business Segments                                     
102: R89         Segment Information (Details) - Schedule of         HTML     41K  
                Identifiable Long-Lived Tangible Assets                          
103: R90         Segment Information (Details) - Schedule of         HTML     37K  
                Identifiable Long-Lived Tangible Assets                          
104: R91         Commitments and Contincengies (Details)             HTML     50K  
105: R92         Commitments and Contincengies (Details) - Schedule  HTML     37K  
                of Supplemental Cash Flow Information Related to                 
                Leases                                                           
106: R93         Commitments and Contincengies (Details) - Schedule  HTML     35K  
                of Lease Term and Discount Rate for the Company?s                
                Operating Lease                                                  
107: R94         Commitments and Contincengies (Details) - Schedule  HTML     45K  
                of Maturity of Lease Liabilities Under Operating                 
                Lease                                                            
108: R95         Subsequent Events (Details)                         HTML     41K  
110: XML         IDEA XML File -- Filing Summary                      XML    216K  
113: XML         XBRL Instance -- ea0202604-10k_avalon_htm            XML   1.94M  
109: EXCEL       IDEA Workbook of Financial Report Info              XLSX    248K  
10: EX-101.CAL  XBRL Calculations -- avco-20231231_cal               XML    211K 
11: EX-101.DEF  XBRL Definitions -- avco-20231231_def                XML   1.41M 
12: EX-101.LAB  XBRL Labels -- avco-20231231_lab                     XML   2.42M 
13: EX-101.PRE  XBRL Presentations -- avco-20231231_pre              XML   1.32M 
 9: EX-101.SCH  XBRL Schema -- avco-20231231                         XSD    332K 
111: JSON        XBRL Instance as JSON Data -- MetaLinks              775±  1.13M  
112: ZIP         XBRL Zipped Folder -- 0001213900-24-033023-xbrl      Zip    573K  


‘EX-97.1’   —   Avalon Globocare Corp. Compensation Recovery Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 97.1

 

AVALON GLOBOCARE CORP.

 

COMPENSATION RECOVERY POLICY

 

(Adopted and approved on November 16, 2023)

 

1. Purpose

 

Avalon GloboCare Corp. (collectively with its subsidiaries, the “Company”) is committed to promoting high standards of honest and ethical business conduct and compliance with applicable laws, rules and regulations. As part of this commitment, the Company has adopted this Compensation Recovery Policy (this “Policy”). This Policy is designed to comply with the requirements of Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Rule 10D-1 promulgated thereunder and the rules of the national securities exchange on which the Company’s securities are traded and explains when the Company will pursue recovery of Incentive Compensation awarded or paid to a Covered Person. Please refer to Exhibit A attached hereto (the “Definitions Exhibit”) for the definitions of capitalized terms used throughout this Policy.

 

2. Recovery of Recoverable Incentive Compensation

 

In the event of a Restatement, the Company will pursue, reasonably promptly, recovery of all Recoverable Incentive Compensation from a Covered Person without regard to such Covered Person’s individual knowledge or responsibility related to the Restatement. Notwithstanding the foregoing, if the Company is otherwise required by this Policy to undertake a Restatement, the Company will not be required to recover the Recoverable Incentive Compensation if the Compensation Committee determines, after exercising a normal due process review of all the relevant facts and circumstances, that (a) a Recovery Exception exists and (b) it would be impracticable to seek such recovery under such facts and circumstances.

 

If such Recoverable Incentive Compensation was not awarded or paid on a formulaic basis, the Company will pursue recovery of the amount that the Compensation Committee determines in good faith should be recovered.

 

3. Other Actions

 

The Compensation Committee may, subject to applicable law, pursue recovery of Recoverable Incentive Compensation in the manner it chooses, including by pursuing reimbursement from the Covered Person of all or part of the compensation awarded or paid, by electing to withhold unpaid compensation, by set-off, or by rescinding or canceling unvested stock or option awards.

 

In the reasonable exercise of its business judgment under this Policy, the Compensation Committee may in its sole discretion determine whether and to what extent additional action is appropriate to address the circumstances surrounding a Restatement to minimize the likelihood of any recurrence and to impose such other discipline as it deems appropriate.

 

 

 

4. No Indemnification or Reimbursement

 

As required by applicable law, notwithstanding the terms of any other policy, program, agreement or arrangement, in no event will the Company or any of its affiliates indemnify or reimburse a Covered Person for any loss of Recoverable Incentive Compensation under this Policy and, to the extent prohibited by law, neither the Company nor any of its affiliates will pay premiums on any insurance policy that would cover a Covered Person’s potential obligations with respect to Recoverable Incentive Compensation under this Policy.

 

5. Administration of Policy

 

The Compensation Committee will have full authority to administer this Policy. The Compensation Committee will, subject to the provisions of this Policy and Rule 10D-1 of the Exchange Act, and the Company’s applicable exchange listing standards, make such determinations and interpretations and take such actions in connection with this Policy as it deems necessary, appropriate or advisable. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act, Rule 10D-1 thereunder and any applicable rules or standards adopted by the Securities and Exchange Commission or any national securities exchange on which the Company’s securities are listed. All determinations and interpretations made by the Compensation Committee will be final, binding and conclusive.

 

6. Other Claims and Rights

 

The requirements of this Policy are in addition to, and not in lieu of, any legal and equitable claims the Company or any of its affiliates may have or any actions that may be imposed by law enforcement agencies, regulators, administrative bodies, or other authorities. Further, the exercise by the Compensation Committee of any rights pursuant to this Policy will not impact any other rights that the Company or any of its affiliates may have with respect to any Covered Person subject to this Policy.

 

2

 

 

7. Acknowledgement by Covered Persons; Condition to Eligibility for Incentive Compensation

 

The Company will provide notice and seek acknowledgement of this Policy from each Covered Person, provided that the failure to provide such notice or obtain such acknowledgement will have no impact on the applicability or enforceability of this Policy. After the Effective Date (and also with respect to any Incentive Compensation Received on or after October 2, 2023 pursuant to a preexisting contract or arrangement), any grant of Incentive Compensation to a Covered Person will be deemed to have been made subject to the terms of this Policy, whether or not such Policy is specifically referenced in the documentation relating to such grant and this Policy shall be deemed to constitute an integral part of the terms of any such grant. All Incentive Compensation subject to this Policy will remain subject to this policy, even if already paid, until the Policy ceases to apply to such Incentive Compensation and any other vesting conditions applicable to such Incentive Compensation are satisfied.

 

8. Amendment; Termination

 

The Board or the Compensation Committee may amend or terminate this Policy at any time. In the event that Section 10D of the Exchange Act, Rule 10D-1 thereunder or the rules of the national securities exchange on which the Company’s securities are traded are modified or supplemented, whether by law, regulation or legal interpretation, such modification or supplement shall be deemed to modify or supplement this Policy to the maximum extent permitted by applicable law.

 

9. Effectiveness

 

Except as otherwise determined in writing by the Compensation Committee, this Policy will apply to any Incentive Compensation that is Received by a Covered Person on or after the Effective Date. This Policy will survive and continue notwithstanding any termination of a Covered Person’s employment with the Company and its affiliates.

 

10. Successors

 

This Policy shall be binding and enforceable against all Covered Persons and their successors, beneficiaries, heirs, executors, administrators, or other legal representatives.

 

3

 

 

Exhibit A

 

AVALON GLOBOCARE CORP.

 

COMPENSATION RECOVERY POLICY

 

DEFINITIONS EXHIBIT

 

Applicable Period” means the three completed fiscal years of the Company immediately preceding the earlier of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes (or reasonably should have concluded) that a Restatement is required or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare a Restatement. The “Applicable Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence.

 

Board” means the Board of Directors of the Company.

 

Compensation Committee” means the Company’s committee of independent directors responsible for executive compensation decisions, or in the absence of such a committee, a majority of the independent directors serving on the Board.

 

Covered Person” means any person who is, or was at any time, during the Applicable Period, an Executive Officer of the Company. For the avoidance of doubt, a Covered Person may include a former Executive Officer that left the Company, retired, or transitioned to an employee role (including after serving as an Executive Officer in an interim capacity) during the Applicable Period.

 

Effective Date” means December 1, 2023.

 

Executive Officer” means the Company’s president, principal executive officer, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person (including an officer of the Company’s parent(s) or subsidiaries) who performs similar policy-making functions for the Company.

 

Financial Reporting Measure” means a measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measure that is derived wholly or in part from such measure (including but not limited to, “non-GAAP” financial measures, such as those appearing in the Company’s earnings releases or Management Discussion and Analysis). Stock price and total shareholder return (and any measures derived wholly or in part therefrom) shall be considered Financial Reporting Measures.

 

4

 

 

Recovery Exception:” A recovery of Recoverable Incentive Compensation shall be subject to a “Recovery Exception” if the Compensation Committee determines in good faith that: (i) pursuing such recovery would violate home country law of the jurisdiction of incorporation of the Company where that law was adopted prior to November 28, 2022 and the Company provides an opinion of home country counsel to that effect acceptable to the Company’s applicable listing exchange; (ii) the direct expense paid to a third party to assist in enforcing this Policy would exceed the Recoverable Incentive Compensation and the Company has (A) made a reasonable attempt to recover such amounts and (B) provided documentation of such attempts to recover to the Company’s applicable listing exchange; or (iii) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.

 

Incentive Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive Compensation does not include any base salaries (except with respect to any salary increases earned wholly or in part based on the attainment of a Financial Reporting Measure performance goal); bonuses paid solely at the discretion of the Compensation Committee or Board that are not paid from a “bonus pool” that is determined by satisfying a Financial Reporting Measure performance goal; bonuses paid solely upon satisfying one or more subjective standards and/or completion of a specified employment period; non-equity incentive plan awards earned solely upon satisfying one or more strategic measures or operational measures; and equity awards that vest solely based on the passage of time and/or attaining one or more non-Financial Reporting Measures. Incentive Compensation includes any Incentive Compensation Received on or after October 2, 2023 pursuant to a preexisting contract or arrangement.

 

Received:” Incentive Compensation is deemed “Received” in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive Compensation award is attained, even if the payment or grant of the Incentive Compensation occurs after the end of that period.

 

Recoverable Incentive Compensation” means the amount of any Incentive Compensation (calculated on a pre-tax basis) Received by a Covered Person during the Applicable Period that is in excess of the amount that otherwise would have been Received if the calculation were based on the Restatement. For Incentive Compensation based on (or derived from) stock price or total shareholder return where the amount of Recoverable Incentive Compensation is not subject to mathematical recalculation directly from the information in the applicable Restatement, the amount will be determined by the Compensation Committee based on a reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Incentive Compensation was Received (in which case, the Company will maintain documentation of such determination of that reasonable estimate and provide such documentation to the Company’s applicable listing exchange).

 

Restatement” means an accounting restatement of any of the Company’s financial statements filed with the Securities and Exchange Commission under the Exchange Act, or the Securities Act of 1933, as amended, due to the Company’s material noncompliance with any financial reporting requirement under U.S. securities laws, regardless of whether the Company or Covered Person misconduct was the cause for such restatement. “Restatement” includes any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements (commonly referred to as “Big R” restatements), or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (commonly referred to as “little r” restatements).

 

 

5

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:4/15/24
For Period end:12/31/23NT 10-K
12/1/23
11/16/23
10/2/23
11/28/22
 List all Filings 


51 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Avalon GloboCare Corp.            8-K:1,2,9   3/27/24   12:587K                                   EdgarAgents LLC/FA
11/22/23  Avalon GloboCare Corp.            8-K:1,9    11/17/23   11:329K                                   EdgarAgents LLC/FA
10/13/23  Avalon GloboCare Corp.            8-K:1,2,3,910/12/23   21:2.2M                                   MDM Corp Elec Fi… Inc/FA
 7/10/23  Avalon GloboCare Corp.            8-K:1,2,3,9 7/07/23   15:1.1M                                   EdgarAgents LLC/FA
 6/16/23  Avalon GloboCare Corp.            8-K:1,7,8,9 6/16/23   12:3.5M                                   EdgarAgents LLC/FA
 5/26/23  Avalon GloboCare Corp.            8-K:1,2,3,9 5/26/23   19:1.8M                                   EdgarAgents LLC/FA
 2/13/23  Avalon GloboCare Corp.            8-K:1,2,3,5 2/09/23   14:1.2M                                   EdgarAgents LLC/FA
 1/11/23  Avalon GloboCare Corp.            8-K:5,9     1/09/23   12:267K                                   EdgarAgents LLC/FA
 1/04/23  Avalon GloboCare Corp.            8-K:3,5,9   1/04/23   11:215K                                   EdgarAgents LLC/FA
11/08/22  Avalon GloboCare Corp.            8-K:1,3,5,711/08/22   14:1.2M                                   EdgarAgents LLC/FA
 9/08/22  Avalon GloboCare Corp.            8-K:1,2,9   9/01/22   13:490K                                   EdgarAgents LLC/FA
 8/08/22  Avalon GloboCare Corp.            8-K:1,3,9   8/05/22   12:381K                                   EdgarAgents LLC/FA
 7/27/22  Avalon GloboCare Corp.            8-K:1,3,9   7/25/22   12:269K                                   EdgarAgents LLC/FA
 6/08/22  Avalon GloboCare Corp.            8-K:1,2,3,9 6/08/22   11:212K                                   EdgarAgents LLC/FA
 5/11/22  Avalon GloboCare Corp.            10-Q        3/31/22   75:5.2M                                   EdgarAgents LLC/FA
 4/29/22  Avalon GloboCare Corp.            8-K:1,2,3,9 4/29/22   11:249K                                   EdgarAgents LLC/FA
 3/30/22  Avalon GloboCare Corp.            10-K       12/31/21  100:8.9M                                   EdgarAgents LLC/FA
12/22/21  Avalon GloboCare Corp.            8-K:1,2,3,912/17/21   12:239K                                   EdgarAgents LLC/FA
 7/14/21  Avalon GloboCare Corp.            8-K:1,9     7/08/21    2:174K                                   EdgarAgents LLC/FA
 2/24/20  Avalon GloboCare Corp.            8-K:5,9     2/20/20    4:83K                                    EdgarAgents LLC/FA
12/13/19  Avalon GloboCare Corp.            8-K:1,9    12/13/19    3:256K                                   EdgarAgents LLC/FA
10/21/19  Avalon GloboCare Corp.            8-K:1,9    10/18/19    2:51K                                    EdgarAgents LLC/FA
 9/03/19  Avalon GloboCare Corp.            8-K:1,2,9   8/29/19    3:71K                                    EdgarAgents LLC/FA
 4/26/19  Avalon GloboCare Corp.            8-K:1,8,9   4/25/19    6:656K                                   EdgarAgents LLC/FA
 4/08/19  Avalon GloboCare Corp.            8-K:1,3,5,9 4/05/19    3:156K                                   EdgarAgents LLC/FA
 3/22/19  Avalon GloboCare Corp.            8-K:1,2,9   3/18/19    2:29K                                    EdgarAgents LLC/FA
 1/04/19  Avalon GloboCare Corp.            8-K:5,9     1/03/19    4:68K                                    S2 Filings LLC/FA
10/29/18  Avalon Globocare Corp.            8-K:1,9    10/23/18    2:1.2M                                   S2 Filings LLC/FA
 8/07/18  Avalon Globocare Corp.            S-1/A                  8:3.1M                                   S2 Filings LLC/FA
 7/31/18  Avalon Globocare Corp.            8-K:1,3,5,9 7/30/18    2:100K                                   S2 Filings LLC/FA
 7/27/18  Avalon Globocare Corp.            S-1/A                  6:3.2M                                   S2 Filings LLC/FA
 7/20/18  Avalon Globocare Corp.            S-1/A                108:9.9M                                   S2 Filings LLC/FA
 7/10/18  Avalon Globocare Corp.            8-K:1,3,5,9 7/05/18    2:102K                                   S2 Filings LLC/FA
 6/06/18  Avalon Globocare Corp.            8-K:1,3,5,8 6/04/18    3:153K                                   S2 Filings LLC/FA
 5/11/18  Avalon Globocare Corp.            10-Q        3/31/18   97:4.8M                                   S2 Filings LLC/FA
 4/26/18  Avalon Globocare Corp.            8-K/A:1,3,5 4/13/18    4:224K                                   S2 Filings LLC/FA
 4/19/18  Avalon Globocare Corp.            S-1                    4:2.2M                                   S2 Filings LLC/FA
 4/18/18  Avalon Globocare Corp.            8-K:1,3,9   4/13/18    2:142K                                   S2 Filings LLC/FA
 4/04/18  Avalon Globocare Corp.            8-K:5,9     4/03/18    3:39K                                    S2 Filings LLC/FA
11/07/17  Avalon Globocare Corp.            8-K:5,9    11/01/17    3:169K                                   S2 Filings LLC/FA
10/26/17  Avalon Globocare Corp.            8-K:1,2,3,910/20/17    7:393K                                   S2 Filings LLC/FA
 8/14/17  Avalon Globocare Corp.            10-Q        6/30/17   74:3.2M                                   S2 Filings LLC/FA
 7/07/17  Avalon Globocare Corp.            S-1/A¶                 7:1.6M                                   S2 Filings LLC/FA
 4/28/17  Avalon Globocare Corp.            8-K:5,9     4/28/17    3:111K                                   S2 Filings LLC/FA
 3/07/17  Avalon Globocare Corp.            8-K:1,2,3,9 3/03/17    4:266K                                   S2 Filings LLC/FA
 2/21/17  Avalon Globocare Corp.            8-K:1,3,5,9 2/21/17    4:191K                                   S2 Filings LLC/FA
 1/11/17  Avalon Globocare Corp.            8-K:1,5,9   1/11/16    2:102K                                   S2 Filings LLC/FA
12/23/16  Avalon Globocare Corp.            8-K:1,9    12/22/16    2:162K                                   S2 Filings LLC/FA
12/21/16  Avalon Globocare Corp.            8-K:1,3,9  12/19/16    2:70K                                    S2 Filings LLC/FA
12/02/16  Avalon Globocare Corp.            8-K:1,5,9  12/01/16    2:84K                                    S2 Filings LLC/FA
10/19/16  Avalon Globocare Corp.            8-K:1,2,3,510/18/16    9:680K                                   S2 Filings LLC/FA
Top
Filing Submission 0001213900-24-033023   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 8:10:53.4pm ET